The FDA approved several drugs throughout November for the treatment of diseases including leukemia and biliary tract cancer, in addition to a diagnostic for solid cancers. Several cancer therapies ...
Zacks Investment Research on MSN
Here's how AbbVie's oncology drugs are aiding top-line growth
AbbVie ABBV has been significantly expanding its presence in the oncology space. What started initially as a two-drug ...
China Releases First Novel Drugs List for Commercial Insurance, With CAR-T Therapies Leading the Way
(Yicai) Dec. 8 -- China introduced its first Commercial Health Insurance Innovative Drug List that includes five chimeric ...
AbbVie ABBV has been expanding its oncology portfolio over the past few years. While the company was originally focused on two blood-cancer drugs — Imbruvica and Venclexta — it has since built a ...
Intermittent shortages of various injectable chemotherapy drugs have become a regular part of cancer care, with oncology practices reporting that despite their best efforts to mitigate supply ...
Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company’s primary focus is on diabetes and obesity drugs, the oncology franchise also remains a key ...
As China's aging population increases demand for therapies treating everything from cancer and diabetes to dementia, the ...
pular drugs linked to elevated cancer risk, but some doctors aren't convinced. June 14, 2010— -- Some widely used blood pressure drugs may be associated with an increased risk of cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback